YishengBio received approval from Philippines for Phase 2/3 clinical trials of PIKA recombinant COVID-19 vaccine
YishengBio Co., Ltd., ("YishengBio"), a biopharmaceutical company dedicated to discovery, development, manufacturing and commercialization of new generations of vaccines and therapeutic biologics, announced that it...